Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Microbiology

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JCM.41.2.742-750.2003PMID 12574276PMCID PMC149673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics.

  2003cited by this paper
• In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication

  2002cited by this paper
• The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

  2002cited by this paper
• Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

  2001cited by this paper
• Treatment of influenza with neuraminidase inhibitors: virological implications.

  2001cited by this paper
• Position statement: global neuraminidase inhibitor susceptibility network.

  2001influential reference
• Resistance of influenza viruses to neuraminidase inhibitors--a review.

  2000influential reference
• Influenza virus neuraminidase inhibitors.

  2000cited by this paper
• Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors

  2000influential reference
• Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.

  2000influential reference
• Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies

  2000cited by this paper
• Management of Influenza

  2000cited by this paper
• BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.

  2000cited by this paper
• Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection

  1998cited by this paper
• Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071

  1998cited by this paper
• Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.

  1998influential reference
• Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en

  1996cited by this paper
• Drug design. A rational attack on influenza.

  1993cited by this paper
• Rational design of potent sialidase-based inhibitors of influenza virus replication

  1993influential reference
• Acknowledgments

  1993cited by this paper
• A rational attack on influenza

  1993cited by this paper
• The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

  1992cited by this paper
• Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution.

  1991cited by this paper
• Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

  1979cited by this paper

• Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets.

  2025cites this paper
• Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation

  2025cites this paper
• Laboratory Methods for Monitoring Influenza Antiviral Resistance.

  2025cites this paper
• Catch, Cut, or Block? Versatile 4‐N‐Derivatized Sialyl Glycosides for Influenza Virus Neuraminidase Detection and Purification

  2025cites this paper
• Influenza neuraminidase mutations and resistance to neuraminidase inhibitors

  2024cites this paper
• LOW ANTIVIRAL RESISTANCE IN INFLUENZA A AND B VIRUSES ISOLATED IN MEXICO FROM 2010 TO 2023.

  2024cites this paper
• An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo

  2023cites this paper
• Pyocyanin as a safe aquaculture drug for the control of vibriosis in shrimp recirculating aquaculture system (RAS)

  2022cites this paper
• The inhibition effects and mechanisms of sulfated chitooligosaccharides on influenza A virus in vitro and in vivo.

  2022cites this paper
• Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design

  2022cites this paper
• β-Lactamase-Mediated Fragmentation: Historical Perspectives and Recent Advances in Diagnostics, Imaging, and Antibacterial Design.

  2022cites this paper
• Inherent Serum Inhibition of Influenza Virus Neuraminidases

  2021cites this paper
• Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.

  2021cites this paper
• Influenza A (N1-N9) and Influenza B (B/Vic and B/Yam) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine design

  2021cites this paper
• Anti-infection Strategies

  2021cites this paper
• Skin and soft tissue infections

  2021cites this paper
• Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018–2019

  2021cites this paper
• A cephalosporin-chemiluminescent conjugate increases beta-lactamase detection sensitivity by four orders of magnitude.

  2020cites this paper
• A human cell polarity protein Lgl2 regulates influenza A virus nucleoprotein exportation from nucleus in MDCK cells

  2020cites this paper
• A human cell polarity protein Lgl2 regulates influenza A virus nucleoprotein exportation from nucleus in MDCK cells

  2020cites this paper
• Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors

  2020cites this paper
• Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus

  2020cites this paper
• Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry

  2019cites this paper
• Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference

  2019cites this paper
• Community spread and late season increased incidence of oseltamivir‐resistant influenza A(H1N1) viruses in Norway 2016

  2019cites this paper
• Design, synthesis, bioactivity, and DFT calculation of 2-thiazolyl-hydrazone derivatives as influenza neuraminidase inhibitors

  2019cites this paper
• Reduced Sensitivity of Infl uenza A ( H 5 N 1 ) to Oseltamivir

  2019cites this paper
• Influenza virus susceptibility to antiviral drugs : drug susceptibility profiling, whole-genome mutational landscape and selective pressure footprints

  2018cites this paper
• Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus

  2018cites this paper
• Antiviral Methods and Protocols

  2018cites this paper
• Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses

  2018cites this paper
• Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015

  2018cites this paper
• Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

  2018cites this paper
• Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study

  2018cites this paper
• Production and Characterization of Synthetic ErbB2 Virosomes for Vaccination Against Breast Cancer

  2018cites this paper
• Rapid and simple detection of Tamiflu-resistant influenza virus: Development of oseltamivir derivative-based lateral flow biosensor for point-of-care (POC) diagnostics

  2018cites this paper
• Replacement of neuraminidase inhibitor‐susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009‐2013, South Africa

  2018cites this paper
• An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac

  2018cites this paper
• Methods and Current Trends in Determination of Neuraminidase Activity and Evaluation of Neuraminidase Inhibitors

  2018cites this paper
• Development of hybrid haemagglutinin pseudotyped lentiviruses to assess heterosubtypic immunity to influenza

  2017cites this paper
• Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway

  2017cites this paper
• Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection

  2017influential citation
• Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study ( IRIS ) Running title : Resistance to Neuraminidase Inhibitors

  2017cites this paper
• The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients

  2017cites this paper
• Development of lentiviral pseudotypes for surveillance studies on animal influenza viruses

  2017cites this paper
• High-Efficiency Capture of Drug Resistant-Influenza Virus by Live Imaging of Sialidase Activity

  2016cites this paper
• Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance.

  2016cites this paper
• Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014–2015 influenza season in Alberta, Canada

  2016cites this paper
• Functional balance between neuraminidase and haemagglutinin in influenza viruses.

  2016cites this paper
• A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro

  2016cites this paper
• Design, Synthesis, and Evaluation of 3‐((4‐(t‐Butyl)‐2‐(2‐benzylidenehydrazinyl)thiazol‐5‐yl)methyl)quinolin‐2(1H)‐ones as Neuraminidase Inhibitors

  2016cites this paper
• Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

  2016cites this paper
• Determining drug efficacy parameters for mathematical models of influenza

  2015cites this paper
• Development of a surface plasmon resonance assay to measure the binding affinity of wild‐type influenza neuraminidase and its H274Y mutant to the antiviral drug zanamivir

  2015influential citation
• Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors

  2015cites this paper
• Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility

  2015cites this paper
• A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild‐type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir

  2015influential citation
• Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.

  2015cites this paper
• Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir.

  2015cites this paper
• Refugee crisis demands European Union-wide surveillance!

  2015cites this paper
• Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.

  2015cites this paper
• Susceptibility Test Methods: Viruses*

  2015cites this paper
• Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.

  2015cites this paper
• Single dose Peramivir for the Treatment of Acute Seasonal Influenza: Integrated Analysis of Efficacy and Safety from Two Placebo-Controlled Trials

  2015cites this paper
• ESwab challenges influenza virus propagation in cell cultures.

  2014cites this paper
• In vitro and in vivo anti-influenza virus activities of flavonoids and related compounds as components of Brazilian propolis (AF-08)

  2014cites this paper
• Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

  2014cites this paper
• Inhibition effect of flavonoid compounds against neuraminidase expressed in Pichia pastoris

  2014cites this paper
• Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.

  2014cites this paper
• A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade

  2014cites this paper
• Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.

  2014cites this paper
• Antiviral Drugs for Influenza and Other Respiratory Virus Infections

  2014influential citation
• Antiviral resistance in influenza viruses: laboratory testing.

  2014cites this paper
• Resistance of human cytomegalovirus to ganciclovir/valganciclovir: a comprehensive review of putative resistance pathways.

  2014cites this paper
• Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

  2013cites this paper
• Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir‐resistant influenza A viruses

  2013cites this paper
• Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding

  2013cites this paper
• Characterization of H7N9 influenza A viruses isolated from humans

  2013cites this paper
• A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.

  2013cites this paper
• Hospitalized with Influenza A and B infections

  2013cites this paper
• Surveillance for antiviral resistance

  2013cites this paper
• Methods to determine mechanism of action of anti-influenza inhibitors.

  2013cites this paper
• Determination of Neuraminidase Kinetic Constants Using Whole Influenza Virus Preparations and Correction for Spectroscopic Interference by a Fluorogenic Substrate

  2013cites this paper
• Genetic diversity among pandemic 2009 influenza viruses isolated from a transmission chain

  2013cites this paper
• Application of electrolysis for inactivation of an antiviral drug that is one of possible selection pressure to drug-resistant influenza viruses.

  2013cites this paper
• Assessment of Health Risks Associated with Waste Handling Among Sanitation Workers at Prampram

  2013cites this paper
• Arylamine N-Acetyltransferases from mycobacteria : investigations of a potential target for anti-tubercular therapy

  2013cites this paper
• Recent progress and challenges in the discovery of new neuraminidase inhibitors

  2013cites this paper
• Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.

  2013cites this paper
• Germacrone inhibits early stages of influenza virus infection.

  2013cites this paper
• Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria

  2013cites this paper
• I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses

  2013cites this paper
• Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors

  2013cites this paper
• Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments.

  2013cites this paper
• A surface plasmon resonance assay to determine the effect of influenza neuraminidase mutations on its affinity with antiviral drugs.

  2013cites this paper
• Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

  2013cites this paper
• Evaluation of Three Influenza Neuraminidase Inhibition Assays for Use in a Public Health Laboratory Setting during the 2011–2012 Influenza Season

  2013cites this paper
• Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks

  2012cites this paper
• Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.

  2012cites this paper
• Management of Influenza Virus Infections with Neuraminidase Inhibitors

  2012cites this paper